| # | Drug | Count |
|---|---|---|
| 0 | ATAZANAVIR | 9 |
| 1 | RITONAVIR | 9 |
| 2 | HYDROXYCHLOROQUINE SULFATE | 8 |
| 3 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 7 |
| 4 | ESOMEPRAZOLE | 7 |
| 5 | ESOMEPRAZOLE MAGNESIUM | 7 |
| 6 | METHOTREXATE | 7 |
| 7 | METHOTREXATE SODIUM | 7 |
| 8 | MISOPROSTOL | 5 |
| 9 | NAPROXEN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN RHO(D) IMMUNE GLOBULIN | 2 | 0.0019 |
| 1 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 2 | ATAZANAVIR | 9 | 0.0006 |
| 3 | MIFEPRISTONE | 3 | 0.0006 |
| 4 | MISOPROSTOL | 5 | 0.0005 |
| 5 | ASFOTASE ALFA | 4 | 0.0004 |
| 6 | LOPINAVIR AND RITONAVIR | 4 | 0.0003 |
| 7 | ZIDOVUDINE | 2 | 0.0002 |
| 8 | CARBOXYMETHYLCELLULOSE SODIUM | 1 | 0.0002 |
| 9 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 7 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin Antagonist [EPC] | 3 | 0.0006 |
| 1 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 4 | 0.0004 |
| 2 | Prostaglandin E1 Analog [EPC] | 5 | 0.0003 |
| 3 | Protease Inhibitor [EPC] | 13 | 0.0003 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 13 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0001 |
| 7 | Intestinal Lipase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |